{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:41:03Z","timestamp":1791207663162,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.molmed.2012.09.004","type":"journal-article","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T05:15:18Z","timestamp":1349500518000},"page":"667-678","source":"Crossref","is-referenced-by-count":72,"title":["Cancer syndromes and therapy by stop-codon readthrough"],"prefix":"10.1016","volume":"18","author":[{"given":"Renata","family":"Bordeira-Carri\u00e7o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"P\u00eago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2012.09.004_bib0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","article-title":"Introducing sense into nonsense in treatments of human genetic diseases","volume":"24","author":"Linde","year":"2008","journal-title":"Trends Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrg2402","article-title":"The multiple lives of NMD factors: balancing roles in gene and genome regulation","volume":"9","author":"Isken","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0445","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2012.07.007","article-title":"Pharmaceutical therapies to recode nonsense mutations in inherited diseases","volume":"136","author":"Lee","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2012.09.004_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1479-7364-4-2-69","article-title":"The Human Gene Mutation Database: providing a comprehensive central mutation database for molecular diagnostics and personalized genomics","volume":"4","author":"Stenson","year":"2009","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.molmed.2012.09.004_bib0025","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/MCP.0b013e32833f1d00","article-title":"Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis","volume":"16","author":"Sloane","year":"2010","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.molmed.2012.09.004_bib0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s004390100598","article-title":"Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?","volume":"109","author":"Kerr","year":"2001","journal-title":"Hum. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nature10275","article-title":"A continuum model for tumour suppression","volume":"476","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2012.09.004_bib0040","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1053\/j.gastro.2009.02.065","article-title":"Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression","volume":"136","author":"Oliveira","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2012.09.004_bib0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/gut.2006.093310","article-title":"The canonical Wnt signalling pathway and its APC partner in colon cancer development","volume":"56","author":"Schneikert","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2012.09.004_bib0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13402-011-0010-3","article-title":"Pathology of hereditary breast cancer","volume":"34","author":"van der Groep","year":"2011","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.molmed.2012.09.004_bib0055","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/hmg\/ddp046","article-title":"Germline CDH1 deletions in hereditary diffuse gastric cancer families","volume":"18","author":"Oliveira","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0060","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jmg.2009.074237","article-title":"Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research","volume":"47","author":"Fitzgerald","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","article-title":"Molecular genetics of colorectal cancer","volume":"6","author":"Fearon","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/nar\/24.1.121","article-title":"APC gene: database of germline and somatic mutations in human tumors and cell lines","volume":"24","author":"Beroud","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2012.09.004_bib0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1476-4598-10-101","article-title":"Messing up disorder: how do missense mutations in the tumor suppressor protein APC lead to cancer?","volume":"10","author":"Minde","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.molmed.2012.09.004_bib0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-4-22","article-title":"Familial adenomatous polyposis","volume":"4","author":"Half","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.molmed.2012.09.004_bib0085","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1111\/j.1463-1318.2010.02218.x","article-title":"Attenuated familial adenomatous polyposis: results from an international collaborative study","volume":"12","author":"Knudsen","year":"2010","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.molmed.2012.09.004_bib0090","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3748\/wjg.v13.i19.2727","article-title":"Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing","volume":"13","author":"Papp","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/hmg\/7.3.507","article-title":"Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation","volume":"7","author":"Marsh","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0100","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/gut.2009.198499","article-title":"Peutz-Jeghers syndrome: a systematic review and recommendations for management","volume":"59","author":"Beggs","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2012.09.004_bib0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jmg.2003.010900","article-title":"Genotype-phenotype correlations in Peutz-Jeghers syndrome","volume":"41","author":"Amos","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0110","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/cncr.26390","article-title":"Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database","volume":"118","author":"Ognjanovic","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.molmed.2012.09.004_bib0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.molmed.2012.09.004_bib0120","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1586\/14737140.6.8.1205","article-title":"Breast cancer susceptibility testing: past, present and future","volume":"6","author":"Goldberg","year":"2006","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.molmed.2012.09.004_bib0125","first-page":"1068","article-title":"Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer","volume":"60","author":"Hakansson","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0130","first-page":"42","article-title":"A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families","volume":"58","author":"Serova","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4161\/cbt.3.6.841","article-title":"Understanding germ-line mutations in BRCA1","volume":"3","author":"Szabo","year":"2004","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.molmed.2012.09.004_bib0140","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1038\/onc.2008.62","article-title":"The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers","volume":"27","author":"Karam","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2012.09.004_bib0145","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1261\/rna.2401811","article-title":"Mechanism of escape from nonsense-mediated mRNA decay of human beta-globin transcripts with nonsense mutations in the first exon","volume":"17","author":"Neu-Yilik","year":"2011","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2012.09.004_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0945-053X(99)00056-6","article-title":"Nonsense mutations in the COL1A1 gene preferentially reduce nuclear levels of mRNA but not hnRNA in osteogenesis imperfecta type I cell strains","volume":"19","author":"Slayton","year":"2000","journal-title":"Matrix Biol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0155","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/sj.gt.3302199","article-title":"Gene therapy approaches for osteogenesis imperfecta","volume":"11","author":"Niyibizi","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.molmed.2012.09.004_bib0160","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/wrna.95","article-title":"Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases","volume":"2","author":"Keeling","year":"2011","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.molmed.2012.09.004_bib0165","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/hmg\/11.23.2805","article-title":"The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons","volume":"11","author":"Perrin-Vidoz","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0170","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/hmg\/10.7.721","article-title":"The ABC of APC","volume":"10","author":"Fearnhead","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0175","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/j.gastro.2010.04.047","article-title":"Allele-specific expression of APC in adenomatous polyposis families","volume":"139","author":"Castellsague","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2012.09.004_bib0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.jid.5700031","article-title":"Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey\u2013Hailey disease","volume":"126","author":"Kellermayer","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jgm.1140","article-title":"Drug-induced readthrough of premature stop codons leads to the stabilization of laminin \u03b12 chain mRNA in CMD myotubes","volume":"10","author":"Allamand","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.molmed.2012.09.004_bib0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2012.09.004_bib0195","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1017\/S1355838200001242","article-title":"Suppression of eukaryotic translation termination by selected RNAs","volume":"6","author":"Carnes","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2012.09.004_bib0200","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1261\/rna.5280103","article-title":"Stop codon suppression via inhibition of eRF1 expression","volume":"9","author":"Carnes","year":"2003","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2012.09.004_bib0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/j.1460-2075.1985.tb02338.x","article-title":"Amber, ochre and opal suppressor tRNA genes derived from a human serine tRNA gene","volume":"4","author":"Capone","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2012.09.004_bib0210","doi-asserted-by":"crossref","first-page":"184393","DOI":"10.1155\/2011\/184393","article-title":"Mammalian models of Duchenne Muscular Dystrophy: pathological characteristics and therapeutic applications","volume":"2011","author":"Nakamura","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0215","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI28523","article-title":"Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin","volume":"117","author":"Linde","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2012.09.004_bib0220","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/sj.ejhg.5201889","article-title":"The efficiency of nonsense-mediated mRNA decay is an inherent character and varies among different cells","volume":"15","author":"Linde","year":"2007","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0225","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1261\/rna.5147804","article-title":"Leaky termination at premature stop codons antagonizes nonsense-mediated mRNA decay in S. cerevisiae","volume":"10","author":"Keeling","year":"2004","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2012.09.004_bib0230","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/nass\/nrl119","article-title":"A novel therapeutic approach for genetic diseases by introduction of suppressor tRNA","volume":"50","author":"Sako","year":"2006","journal-title":"Nucleic Acids Symp. Ser. (Oxf.)"},{"key":"10.1016\/j.molmed.2012.09.004_bib0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1039\/B712690P","article-title":"Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases","volume":"6","author":"Hainrichson","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.molmed.2012.09.004_bib0240","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejmg.2006.04.003","article-title":"Translational readthrough induction of pathogenic nonsense mutations","volume":"49","author":"Kellermayer","year":"2006","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0245","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/hmg\/ddp030","article-title":"Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo","volume":"18","author":"Heier","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0250","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jb\/mvg203","article-title":"Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice","volume":"134","author":"Arakawa","year":"2003","journal-title":"J. Biochem."},{"key":"10.1016\/j.molmed.2012.09.004_bib0255","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.bmc.2010.03.060","article-title":"Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations","volume":"18","author":"Nudelman","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.molmed.2012.09.004_bib0260","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/jm801640k","article-title":"Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations","volume":"52","author":"Nudelman","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molmed.2012.09.004_bib0265","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1073\/pnas.0711795105","article-title":"PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model","volume":"105","author":"Du","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.09.004_bib0270","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0091270006297140","article-title":"Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers","volume":"47","author":"Hirawat","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0275","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cvr\/cvp116","article-title":"Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels","volume":"83","author":"Teng","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.molmed.2012.09.004_bib0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.crvi.2006.09.001","article-title":"Aminoglycosides and other factors promoting stop codon readthrough in human cells","volume":"330","author":"Diop","year":"2007","journal-title":"C. R. Biol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0285","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1128\/MCB.20.9.3116-3124.2000","article-title":"Suppression of nonsense mutations in cell culture and mice by multimerized suppressor tRNA genes","volume":"20","author":"Buvoli","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0290","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tim.2006.12.002","article-title":"Regulated translational bypass of stop codons in yeast","volume":"15","author":"von der Haar","year":"2007","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0295","doi-asserted-by":"crossref","first-page":"8650","DOI":"10.1073\/pnas.0510817103","article-title":"In vivo incorporation of multiple unnatural amino acids through nonsense and frameshift suppression","volume":"103","author":"Rodriguez","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.09.004_bib0300","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1089\/10430349950017194","article-title":"Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA","volume":"10","author":"Panchal","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.molmed.2012.09.004_bib0305","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BJ20100699","article-title":"NMD: RNA biology meets human genetic medicine","volume":"430","author":"Bhuvanagiri","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2012.09.004_bib0310","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1261\/rna.2024810","article-title":"In vitro incorporation of nonnatural amino acids into protein using tRNA(Cys)-derived opal, ochre, and amber suppressor tRNAs","volume":"16","author":"Gubbens","year":"2010","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2012.09.004_bib0315","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03060","article-title":"A faux 3\u2032-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay","volume":"432","author":"Amrani","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2012.09.004_bib0320","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/cr800409e","article-title":"Nonviral vectors for gene delivery","volume":"109","author":"Mintzer","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molmed.2012.09.004_bib0325","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jconrel.2010.01.018","article-title":"Targeted gene delivery into peripheral sensorial neurons mediated by self-assembled vectors composed of poly(ethylene imine) and tetanus toxin fragment c","volume":"143","author":"Oliveira","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.molmed.2012.09.004_bib0330","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/mp200394t","article-title":"Nanomedicine(s) under the microscope","volume":"8","author":"Duncan","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.molmed.2012.09.004_bib0335","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/gut.2008.169805","article-title":"Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons","volume":"59","author":"Zilberberg","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2012.09.004_bib0340","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00109-001-0317-z","article-title":"Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system","volume":"80","author":"Keeling","year":"2002","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.molmed.2012.09.004_bib0345","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1093\/nar\/gkq1277","article-title":"Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides","volume":"39","author":"Floquet","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2012.09.004_bib0350","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1093\/hmg\/ddn249","article-title":"Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer","volume":"17","author":"Simoes-Correia","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2012.09.004_bib0355","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.yexcr.2009.02.020","article-title":"E-cadherin mutations and cell motility: a genotype-phenotype correlation","volume":"315","author":"Mateus","year":"2009","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.molmed.2012.09.004_bib0360","doi-asserted-by":"crossref","first-page":"e23188","DOI":"10.1371\/journal.pone.0023188","article-title":"ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperones","volume":"6","author":"Figueiredo","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2012.09.004_bib0365","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature10913","article-title":"A new understanding of the decoding principle on the ribosome","volume":"484","author":"Demeshkina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2012.09.004_bib0370","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.1023","article-title":"Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations","volume":"49","author":"Wagner","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0375","first-page":"15","article-title":"Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results","volume":"22","author":"Politano","year":"2003","journal-title":"Acta Myol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0380","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.22024","article-title":"Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy","volume":"67","author":"Malik","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0385","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1164\/ajrccm.161.3.9904116","article-title":"A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations","volume":"161","author":"Wilschanski","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.molmed.2012.09.004_bib0390","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1164\/ajrccm.163.7.2004001","article-title":"Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis","volume":"163","author":"Clancy","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.molmed.2012.09.004_bib0395","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJMoa022170","article-title":"Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations","volume":"349","author":"Wilschanski","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2012.09.004_bib0400","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1165\/rcmb.2006-0173OC","article-title":"No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations","volume":"37","author":"Clancy","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.molmed.2012.09.004_bib0405","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1741-7015-5-5","article-title":"In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study","volume":"5","author":"Sermet-Gaudelus","year":"2007","journal-title":"BMC Med."},{"key":"10.1016\/j.molmed.2012.09.004_bib0410","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(08)61168-X","article-title":"Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial","volume":"372","author":"Kerem","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2012.09.004_bib0415","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.201001-0137OC","article-title":"Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis","volume":"182","author":"Sermet-Gaudelus","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.molmed.2012.09.004_bib0420","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1183\/09031936.00120910","article-title":"Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis","volume":"38","author":"Wilschanski","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.molmed.2012.09.004_bib0425","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood-2005-03-1307","article-title":"Aminoglycoside suppression of nonsense mutations in severe hemophilia","volume":"106","author":"James","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2012.09.004_bib0430","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1538-7836.2006.02057.x","article-title":"Gentamicin induces sub-therapeutic levels of coagulation factor VII in patients with nonsense mutations","volume":"4","author":"Pinotti","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.molmed.2012.09.004_bib0435","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/01.wnl.0000194212.31318.fc","article-title":"Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency","volume":"66","author":"Schroers","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2012.09.004_bib0440","doi-asserted-by":"crossref","first-page":"e13659","DOI":"10.1371\/journal.pone.0013659","article-title":"The effect of gentamicin-induced readthrough on a novel premature termination codon of CD18 leukocyte adhesion deficiency patients","volume":"5","author":"Simon","year":"2010","journal-title":"PLoS ONE"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491412001785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491412001785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T02:09:16Z","timestamp":1714442956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491412001785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":88,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1471491412001785"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2012.09.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}